Fear of ruptures spurs recall of silicone breast implants in France

NewsGuard 100/100 Score

Breast enhancement surgery utilizes implants that are essentially bags containing silicone gel. One of the commonest complications of this procedure is the rupture of these silicone implants that may necessitate a repeat procedure. In a new development the implants made French company Poly Implant Prothese (PIP), have reportedly double the risk of rupturing than other implants. Many breast implants used by Australian women have been recalled overseas for containing unauthorised silicone gel.

A spokeswoman for the Therapeutic Goods Administration said: ''The TGA is aware of this and is investigating the implications for Australian consumers.'' Australasian College of Cosmetic Surgery spokesman Daniel Fleming said women with breast implants need not panic but should contact their surgeon. If they had had the PIP implants they could also go in for an ultrasound examination that can detect if there is a rupture. According to him a rupture is not really dangerous. ''About 3 per cent of implants will rupture after a 10-year period,'' he said. He said an estimation of the number of implants already used is difficult but in his own practice he stopped using this brand for some years now due to his satisfactory results with another brand. Another cosmetic surgeon Dr Anoop Rastogi also echoed this saying that he had stopped using the PIP implants five years ago after some of his patients had ruptured implants.

France's health regulatory agency AFSSAPS, (Agence Francaise de Securite Sanitaire des Produits de Sante), had initially inspected PIP's offices because of reports their implants were twice as likely to rupture than other implants. The agency said there is no sign the implants caused "different complications than those usually seen with other types of breast implants pre-filled with silicone gel" — though it said there was a "higher frequency of rupture and local inflammatory reactions." A recall has already been issued in France and Sweden by PIP.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Fear of ruptures spurs recall of silicone breast implants in France. News-Medical. Retrieved on May 19, 2024 from https://www.news-medical.net/news/20100405/Fear-of-ruptures-spurs-recall-of-silicone-breast-implants-in-France.aspx.

  • MLA

    Mandal, Ananya. "Fear of ruptures spurs recall of silicone breast implants in France". News-Medical. 19 May 2024. <https://www.news-medical.net/news/20100405/Fear-of-ruptures-spurs-recall-of-silicone-breast-implants-in-France.aspx>.

  • Chicago

    Mandal, Ananya. "Fear of ruptures spurs recall of silicone breast implants in France". News-Medical. https://www.news-medical.net/news/20100405/Fear-of-ruptures-spurs-recall-of-silicone-breast-implants-in-France.aspx. (accessed May 19, 2024).

  • Harvard

    Mandal, Ananya. 2018. Fear of ruptures spurs recall of silicone breast implants in France. News-Medical, viewed 19 May 2024, https://www.news-medical.net/news/20100405/Fear-of-ruptures-spurs-recall-of-silicone-breast-implants-in-France.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify increased brain tumor risk with specific contraceptive use